Medine.co.uk

Pantoprazole 20 Mg Gastro-Resistant Tablets

Informations for option: Pantoprazole 20 Mg Gastro-Resistant Tablets, show other option
Document: leaflet MAH GENERIC_PL 00289-1496 change

Pantoprazole 20 mg Gastro-resistant Tablets

Pantoprazole (as pantoprazole sodium sesquihydrate)


Package leaflet: Information for the user


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist.

•    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

•    If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.


What is in this leaflet


1.    What Pantoprazole Tablets are and what they are used for

2.    What you need to know before you take Pantoprazole Tablets

3.    How to take Pantoprazole Tablets

4.    Possible side effects

5.    How to store Pantoprazole Tablets

6.    Contents of the pack and other information

OWhat Pantoprazol Tablets are and what they are used for

Pantoprazole Tablets are a selective "proton pump inhibitor', a medicine which reduces the amount of acid produced in your stomach. It is used for treating acid-related diseases of the stomach and intestine. Pantoprazole Tablets are used for:

Adults and adolescents 12 years of age and above:

- Treating symptoms (e.g. heartburn, acid

regurgitation, pain on swallowing) associated to gastro-oesophageal reflux disease caused by reflux of acid from the stomach.

- Long-term management of reflux oesophagitis (inflammation of the oesophagus accompanied by the regurgitation of stomach acid) and preventing its return.

Adults:

• Preventing duodenal and stomach ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs, for example, ibuprofen) in patients at risk who need to take NSAIDs continuously.

©What you need to know before you take Pantoprazole Tablets

Do not take Pantoprazole Tablets • If you are allergic to pantoprazole or to any of the other ingredients of this medicine (listed in section 6). • If you are allergic to medicines containing other proton pump inhibitors.

Warnings and precautions

Talk to your doctor or pharmacist before taking Pantoprazole Tablets

• If you have severe liver problems. Please tell your doctor if you have ever had problems with your liver. He will check your liver enzymes more frequently, especially when you are taking Pantoprazole Tablets as a long-term treatment. In the case of a rise of liver enzymes the treatment should be stopped.

• if you have ever had a skin reaction after treatment with a medicine similar to Pantoprazole tablets that reduces stomach acid.

• If you need to take medicines called NSAIDs continuously and receive Pantoprazole Tablets because you have an increased risk of developing stomach and intestinal complications. Any increased risk will be assessed according to your own personal risk factors such as your age (65 years old or more), a history of stomach or duodenal ulcers or of stomach or intestinal bleeding.

• If you have reduced body stores or risk factors for reduced vitamin B12 and receive pantoprazole long-term treatment. As with all acid reducing agents, pantoprazole may lead to a reduced absorption of vitamin B12.

• If you are taking a medicine containing atazanavir (for the treatment of HIV-infection) at the same time as pantoprazole, ask your doctor for specific advice. • If you are due to have a specific blood test (Chromogranin A).

Taking a proton pump inhibitor like Pantoprazole Tablets, especially over a period of more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have


osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).

Tell your doctor immediately if you notice any of the following symptoms:

•    an unintentional loss of weight

•    repeated vomiting

•    difficulty in swallowing

•    vomiting blood

•    you look pale and feel weak (anaemia)

•    you notice blood in your stools

•    severe and/or persistent diarrhoea, as Pantoprazole Tablets have been associated with a small increase in infectious diarrhoea.

Your doctor may decide that you need some tests to rule out malignant disease because pantoprazole also alleviates the symptoms of cancer and could cause delay in diagnosing it. If your symptoms continue in spite of your treatment, further investigations will be considered.

If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Pantoprazole tablets. Remember to also mention any other ill-effects like pain in your joints.

If you take Pantoprazole Tablets on a long-term basis (longer than 1 year) your doctor will probably keep you under regular surveillance. You should report any new and exceptional symptoms and circumstances whenever you see your doctor.

Other medicines and Pantoprazole Tablets

Pantoprazole Tablets may influence the effectiveness of other medicines, so tell your doctor if you are taking

•    Medicines such as ketokonazole, itraconazole and posaconazole (used to treat fungal infections) or erlotinib (used for certain types of cancer) because Pantoprazole Tablets may stop these and other medicines from working properly.

•    Warfarin and phenprocoumon, which affect the thickening, or thinning of the blood. You may need further checks.

•    Atazanavir (used to treat HIV-infection).

•    Methotrexate (used to threat autoimmune diseases and cancer)

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Pregnancy and breast-feeding

There are no adequate data from the use of pantoprazole in pregnant women. Excretion into human milk has been reported. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, you should use this medicine only if your doctor considers the benefit for you greater than the potential risk for your unborn child or baby. Ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

If you experience side effects like dizziness or disturbed vision, you should not drive or operate machines. a How to take Pantoprazole Tablets

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

When and how should you take Pantoprazole Tablets?

Take the tablets 1 hour before a meal without chewing or breaking them and swallow them whole with some water.

Unless told otherwise by your doctor, the recommended dose is:

Adults and adolescents 12 years of age and above:

To treat symptoms (e.g. heartburn, acid regurgitation, pain on swallowing) associated to gastro-oesophageal reflux disease

The usual dose is one tablet a day. This dose usually brings relief within 2 - 4 weeks - at most after another 4 weeks. Your doctor will tell you how long to continue taking the medicine. After this any recurring symptoms can be controlled by taking one tablet daily, when required.

For long-term management and for preventing the return of reflux oesophagitis

The usual dose is one tablet a day. If the illness returns, your doctor can double the dose, in which case you can use Pantoprazole 40 mg Tablets instead, one a day. After healing, you can reduce the dose back again to one tablet 20 mg a day.


Adults:

To prevent duodenal and stomach ulcers in patients who need to take NSAIDs continuously

The usual dose is one tablet a day.

Special patient groups:

Hepatic impairment:

-    If you suffer from severe liver problems, you should not take more than one 20 mg tablet a day.

Use in children:

-    Children below 12 years. These tablets are not recommended for use in children below 12 years.

If you take more Pantoprazole Tablets than you should Tell your doctor or pharmacist. There are no known symptoms of overdose.

If you forget to take Pantoprazole Tablets

Do not take a double dose to make up for the forgotten

dose. Take your next normal dose at the usual time.

If you stop taking Pantoprazole Tablets

Do not stop taking these tablets without first talking to your doctor or pharmacist.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

*4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you get any of the following side effects, stop taking these tablets and tell your doctor immediately, or contact the casualty department at your nearest hospital:

-    Serious allergic reactions (frequency rare: may affect up to 1 in 1,000 people): swelling of the tongue and/or throat, difficulty in swallowing, hives (nettle rash), difficulties in breathing, allergic facial swelling (Quincke's oedema / angioedema), severe dizziness with very fast heartbeat and heavy sweating.

-    Serious skin conditions (frequency not known: frequency cannot be estimated from the available data): blistering of the skin and rapid deterioration of your general condition, erosion (including slight bleeding) of eyes, nose, mouth/lips or genitals (Stevens-Johnson-Syndrome, Lyell-Syndrome, Erythema multiforme) and sensitivity to light.

-    Other serious conditions (frequency not known: frequency cannot be estimated from the available data): yellowing of the skin or whites of the eyes (severe damage to liver cells, jaundice) or fever, rash, and enlarged kidneys sometimes with painful urination and lower back pain (serious inflammation of the kidneys which can lead to kidney failure).

Other side effects are:

-    Uncommon (may affect up to 1 in 100 people) headache; dizziness; diarrhoea; feeling sick, vomiting; bloating and flatulence (wind); constipation; dry mouth; abdominal pain and discomfort; skin rash, exanthema, eruption; itching; feeling weak, exhausted or generally unwell; sleep disorders; fracture of the hip, wrist or spine.

-    Rare (may affect up to 1 in 1,000 people) distortion or complete lack of the sense of taste, disturbances in vision such as blurred vision; hives; pain in the joints; muscle pains; weight changes; raised body temperature; swelling of the extremities (peripheral oedema); allergic reactions; depression; breast enlargement in males.

-    Very Rare (may affect up to 1 in 10,000 people) disorientation.

-    Not known (frequency cannot be estimated from the available data)

Hallucination, confusion (especially in patients with a history of these symptoms); decreased sodium level in blood, rash, possibly with pain in the joints, tickling, pricking or burning sensation of the skin.

If you are on Pantoprazole Tablets for more than three months it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood which can cause muscle spasm. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.

Side effects identified through blood tests:

-    Uncommon (may affect up to 1 in 100 people) an increase in liver enzymes.


-    Rare (may affect up to 1 in 1,000 people) an increase in bilirubin; increased fats in the blood, sharp drop in circulating granular white blood cells, associated with high fever.

-    Very Rare (may affect up to 1 in 10,000 people) a reduction in the number of blood platelets, which may cause you to bleed or bruise more than normal; a reduction in the number of white blood cells, which may lead to more frequent infections, coexisting abnormal reduction in the number of red and white blood cells, as well as platelets, which may lead to tiredness, being short of breath and looking pale.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.

How to store Pantoprazole Tablets

Keep this medicine out of the sight and reach of children.

Store below 30°C.

Do not use this medicine after the expiry date, which is stated on the pack after EXP The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

©Contents of the pack and other information

What Pantoprazole Tablets contain

• The active substance is pantoprazole. Each gastro-resistant tablet contains 20mg of pantoprazole (as pantoprazole sodium sesquihydrate)

• The other ingredients are:

Core: Disodium Phosphate Anhydrous, Mannitol (E421), Cellulose Microcrystalline, Croscarmellose Sodium, Magnesium Stearate (vegetable)

Coating: Hypromellose, Triethyl Citrate, Sodium Starch Glycolate (Type A), Methacrylic acid-Ethyl acrylate copolymer and Yellow Iron Oxide (E172). What Pantoprazole Tablets look like and contents of the pack

Pantoprazole 20 mg gastro-resistant Tablets are oval, yellow tablets.

Packs: bottles (HDPE containers with child resistant closure) and blister (aluminium/aluminium blister) Pantoprazole Tablets are available in the following pack sizes:

Packs with 7, 14, 15, 28, 30, 56, 60, 98 & 100 gastro-resistant tablets*.

*Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder TEVA UK Limited Brampton Road,

Hampden Park,

East Sussex,

BN22 9AG United Kingdom Manufacturer Teva Pharma S.L.U.,

Poligono Industrial Malpica, calle C, Numero 4,

50016, Zaragoza,

Spain

Tel: 00 34 976 57 17 84

This leaflet was last approved in September 2016

PL 00289/1496



88146-J